CALAN SR
- Product NDC
- 0025-2712
- 11-digit product format
- 000252712
- Labeler code
- 0025
- Product ID
- 0025-2712_29c25252-03a1-4243-8b60-1ee176c3f79d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA019152
- Marketing category
- NDA
- Marketing start
- 2021-10-25
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0025-2712-31 | 00025271231 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0025-2712-31) | 2021-10-25 | 0000-00-00 | No | No | Current |